Abstract:Licui Li, 1, 2 Huixiu Lu, 1, 3 Yanli Zhang, 4 Qian Li, 4 Shaomin Shi, 4 Yaling Liu 1, 4 1 Department of Dermatology and Venereology, Hebei Medical University, Shijiazhuang, People's Republic of China; 2 Department of Dermatology, Shijiazhuang Gaocheng People's Hospital, Shijiazhuang, People's Republic of China; 3 Department of Dermatology, Shijiazhuang People's Hospital, Shijiazhuang, People's Republic of China; 4 Department of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China Correspondence: Yaling Liu, Department of Dermatology and Venereology, Hebei Medical University, Shijiazhuang, People's Republic of China, Email Objective: To probe into the effect of azelaic acid on psoriasis based on the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Methods: Psoriasis gene expression data were downloaded from the GEO database for differential expression analysis to identify differentially expressed genes (DEGs). KEGG and GSEA analyses were performed to identify important signaling pathways that may be involved in psoriasis progression for subsequent validation. Thirty-six C57BL/6 mice aged 8 weeks old were randomly assigned into the blank control group (n = 9), negative control group (n = 9), psoriasis model group (n = 9), and azelaic acid treat group (n = 9). Mice models of psoriasis were prepared with imiquimod (IMQ) in the latter two groups, and azelaic acid ointment was applied in azelaic acid treat group. Then, hematoxylin-eosin (HE) staining was carried out to detect the effect of azelaic acid on the pathological damage of mice models of psoriasis in each group. HaCaT cells cultured in vitro were divided into blank control group, negative control group (addition of azelaic acid), IL-17 group (20 ng/mL) and IL-17+azelaic acid group, with 3 replicates for each group. Immunofluorescence assay and Western blotting were used to detect the protein expression of PI3K/AKT signaling pathway related molecules. Results: KEGG analysis showed that DEGs were significantly enriched in PI3K-AKT signaling pathway. GSEA analysis showed that PI3K and MTOR signaling pathways were up-regulated in psoriasis, while AUTOPHAGY signaling pathway was down-regulated. HE staining showed that azelaic acid could significantly inhibit the local skin injury in mice caused by IMQ-induced psoriasis. Moreover, azelaic acid can inhibit the expression of PI3K/AKT signaling pathway related proteins phosphorylated (p)-PI3K, p-AKT, p-mammalian target of rapamycin (mTOR), vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), angiogenin-1 and hypoxia-inducible factor-1α (HIF-1α). These results imply that azelaic acid may inhibit the activation of PI3K/AKT signaling pathway and angiogenesis, thereby improving the symptoms of psoriasis. Conclusion: Azelaic acid may inhibit the activation of PI3K/AKT signaling pathway and angiogenesis, thereby improving the symptoms of psoriasis. Keywords: psoriasis, azelaic acid, PI3K/AKT signaling pathway, angiogenesis Psoriasis is a chronic inflammatory dermatosis, which has strong genetic susceptibility and autoimmune pathogenic characteristics. 1 Currently, it is believed that psoriasis has an association with genetic, environmental, immune and other factors. It is mediated by the innate and adaptive immune systems, involves multiple links and pathways, and notably affects the health and quality of life of patients. 2,3 Phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K)/protein kinase B (AKT) signaling pathway is a key pathway for cell survival and a typical autophagy-dependent transduction pathway, which is involved in cell growth, proliferation, vascular proliferation and other processes. 4 PI3K in cells can be activated by corresponding cytokines, further activating downstream AKT and related proteins and triggering corresponding cellular effects. In psoriasis, this pathway can regulate the upstream and downstream related targets together to induce pathological proliferation of epidermal cells. 5 In the upstream, tumor suppressor phosphatase and tensin homolog (PTEN) expression is down-regulated, and in the downstream, mammalian target of rapamycin (mTOR) is abnormally expressed. Inhibiting the PI3K/AKT signaling pathway can repress endothelial growth factors, thereby relieving the symptoms of psoriasis. 6 Azelaic acid gel is a common anti-inflammatory drug. It is mostly used in the treatment of acne, chloasma and cutaneous lesions caused by ultraviolet rays in clinic. 7–9 It can effectively improve the damaged skin barrier function of pati -Abstract Truncated-

DAPT Alleviates Cardiac Dysfunction in Psoriasis by Inhibiting Angiogenesis Through Regulating the Notch/DLL4 Pathway

PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation

Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis

[Effects of DAPT on biological activity of hematopoietic stem cells in mice]

2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation

Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice

Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway

DAPT Attenuates Cadmium-Induced Toxicity in Mice by Inhibiting Inflammation and the Notch/HES-1 Signaling Axis

The Effects of DAPT under Advanced Glycation End Products on Microvascular Endothelial Cells

Biological action of docosahexaenoic acid in a 3D tissue-engineered psoriatic skin model: Focus on the PPAR signaling pathway

Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK/STAT3 signaling pathway

A Potential Therapeutic Approach for Psoriasis Treatment

Human dental pulp stem cells ameliorate the imiquimod-induced psoriasis in mice

Dermal Mesenchymal Stem Cells from Psoriatic Lesions Stimulate HaCaT Cell Proliferation, Differentiation, and Migration via Activating the PI3K/AKT Signaling Pathway

Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-alpha/IFN-gamma-induced inflammatory response in keratinocytes and T cell-derived IL-17

Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation

Daturataturin A Ameliorates Psoriasis by Regulating PPAR Pathway

Psoriasis-associated angiogenesis is mediated by EDIL3

Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways

DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation

Systemic ALA-PDT effectively blocks the development of psoriasis-like lesions and alleviates leucocyte infiltration in the K14-VEGF transgenic mouse